Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 17Neoplasm Metastasis 2Endometrial Neoplasms 2Uterine Cervical Neoplasms 1Unilateral Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma 1Recurrence 1Ovarian Neoplasms 1Neoplasms by Site 1Neoplasms 1Melanoma 1Locally Advanced (Inoperable) or Metastatic Breast Cancer 1Liposarcoma 1Leiomyosarcoma 1Hereditary Sensory and Autonomic Neuropathies 1Head and Neck Neoplasms 1HR+/HER2- Breast Cancer 1HER2 Negative Breast Cancer 1Glioma 1Glioblastoma 1Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer 1Diffuse Intrinsic Pontine Glioma 1Breast Neoplasms, Male 1Breast Diseases 1Brain Neoplasms 1Astrocytoma 1Anatomic Stage II Breast Cancer AJCC v8 1Advanced Breast Cancer 1

Interventions

Radiosurgery 7Temozolomide 6pembrolizumab 4Magnetic Resonance Spectroscopy 4Bevacizumab 4Specimen Handling 3Nivolumab 3abemaciclib 2Watchful Waiting 2Surveys and Questionnaires 2Receptors, Interleukin-8B 2Radiation 2Mental Status and Dementia Tests 2Memantine 2Ipilimumab 2Biopsy 2vorasidenib 1sotorasib 1sapanisertib 1ribociclib 1pertuzumab 1osimertinib 1lenvatinib 1fluciclovine F-18 1entrectinib 1encorafenib 1elacestrant 1dexamethasone acetate 1dexamethasone 21-phosphate 1brivaracetam 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Brain Neoplasms × ribociclib × 30 days × Clear all
NCT05843253 2026-05-29

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

Nationwide Children's Hospital

Phase 2 Recruiting
120 enrolled
CNS

Diffuse Intrinsic Pontine Glioma, Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡